What Are The Long-Term Psychological And Quality Of Life Outcomes For Parkinson's Disease Patients Receiving Cognitive Behavioral Therapy Interventions? : A Systematic Review

What Are The Long-Term Psychological And Quality Of Life Outcomes For Parkinson's Disease Patients Receiving Cognitive Behavioral Therapy Interventions? : A Systematic Review

Authors

  • Mohammad Jathy Oktariansyah Muhammadiyah Bandung Regional General Hospital, Tulungagung Regency, East Java, Indonesia
  • Fifa Yuniarmi Panggul Regional General Hospital, Trenggalek Regency, East Java, Indonesia
  • Kanuyasa Widyatama Eka Candrarini Hospital, Surabaya City, East Java, Indonesia
  • Alestya Putri Jathy Faculty of Medicine, Muhammadiyah University of Malang, East Java, Indonesia

Keywords:

Parkinson's disease, Cognitive Behavioral Therapy, depression, anxiety, quality of life, systematic review

Abstract

Introduction: Parkinson's disease (PD) is a neurodegenerative disorder that significantly affects both motor and non-motor functions, leading to psychological issues such as depression and anxiety. Cognitive Behavioral Therapy (CBT) has emerged as an effective intervention for improving psychological outcomes in PD patients. This study investigates the long-term psychological and quality of life outcomes of PD patients receiving CBT. Methods: A systematic review was conducted adhering to PRISMA guidelines, focusing on studies that included adult PD patients undergoing CBT as a primary intervention. Eligible studies were screened, and data were extracted regarding study design, intervention characteristics, and outcomes related to psychological well-being and quality of life. Results: The review identified 40 studies, demonstrating that CBT significantly reduces depressive and anxiety symptoms in PD patients. Most studies reported positive changes in quality of life, particularly at 6-month follow-ups. However, the sustainability of these benefits over longer periods remains unclear, with some studies indicating diminished effects after 24 months. Discussion: While CBT shows promise in enhancing psychological health among PD patients, the variability in intervention formats and follow-up durations complicates the understanding of long-term efficacy. Factors such as intervention duration, delivery method, and individual patient characteristics may influence treatment outcomes. Conclusion: CBT is a valuable therapeutic approach for managing psychological symptoms in Parkinson's disease. However, further research is necessary to clarify the long-term effects and optimize treatment delivery, ensuring that patients receive sustained psychological support. 

References

A Alnajjar, M. Abouelmagd, Abdulrahman Krayim, Maickel Abdelmeseh, Nagham Bushara, and Yehia Nabil. “Efficacy of Cognitive Behavioral Therapy for Anxiety and Depression in Parkinson’s Disease Patients: An Updated Systematic Review and Meta-Analysis.” Neurological Sciences, 2024.

A. Gloster, C. Hauke, M. Höfler, F. Einsle, T. Fydrich, A. Hamm, Andreas Sthröhle, and H. Wittchen. “Long-Term Stability of Cognitive Behavioral Therapy Effects for Panic Disorder with Agoraphobia: A Two-Year Follow-up Study.” Behaviour Research and Therapy, 2013.

A. Hadinia. “Neuropsychiatrische Symptome Und Der Einfluss Auf Die Lebensqualität Bei Patienten Mit Morbus Parkinson - Kann Eine Kognitive Verhaltenstherapie Helfen?” 2017.

A. Hadinia, A. Meyer, K. Nowak, E. Nyberg, Peter Fuhr, Rolf-Dieter Stieglitz, and U. Gschwandtner. “[Cog- nitive Behavioral Therapy for Anxiety and Depression in Patients with Parkinson's Disease].” Fortschritte Der Neurologie Psychiatrie, 2016.

A. Mulders, A. Moonen, K. Dujardin, M. Kuijf, A. Duits, B. Flinois, R. Handels, Renaud Lopes, and A. Leentjens. “Cognitive Behavioural Therapy for Anxiety Disorders in Parkinson's Disease: Design of a Randomised Controlled Trial to Assess Clinical Effectiveness and Changes in Cerebral Connectivity.” Journal of Psychosomatic Research, 2018.

C. Hong, Shennie Tan, and Tsai-Wei Huang. “Psychotherapy for the Treatment of Anxiety and Depression in Patients With Parkinson Disease: A Meta-Analysis of Randomized Controlled Trials.” Journal of the American Medical Directors Association, 2021.

Chihaya Osawa, Y. Kamei, K. Nozaki, Y. Furusawa, and M. Murata. “Brief Cognitive Behavioral Therapy for Insomnia in Parkinson's Disease: A Case Series Study 1,” 2020.

Chun Yan Wang, D. Li, Shuyang Yu, Mingqia Wang, Qing Guan, and Chun Hui Li. “Cognitive Behavior Therapy Ameliorates Non-Motor Symptoms in Parkinson's Disease,” 2014.

D. Okai, S. Askey‐Jones, M. Samuel, S. O'sullivan, K. Chaudhuri, Anne Martin, J. Mack, Richard G. Brown, and A. David. “Trial of CBT for Impulse Control Behaviors Affecting Parkinson Patients and Their Caregivers.” Neurology, 2013.

D. Pye. “CBT and Mindfulness Psychotherapy for Parkinson’s Disease,” 2015.

Fangyi Luo, Mengfei Ye, Tingting Lv, Baiqi Hu, Jiaqi Chen, Junwei Yan, Anzhe Wang, et al. “Efficacy of Cognitive Behavioral Therapy on Mood Disorders, Sleep, Fatigue, and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-Analysis.” Frontiers in Psychiatry, 2021.

Fangyi Luo, Mengfei Ye, Tingting Lv, Baiqi Hu, Jiaqi Chen, Junwei Yan, Anzhe Wang, et al. “Efficacy of Cognitive Behavioral Therapy on Non-Motor Symptoms and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-Analysis.” medRxiv, 2020.

G. Carey, Renaud Lopes, A. Moonen, A. Mulders, J. D. de Jong, Grégory Kuchcinski, L. Defebvre, M. Kuijf, K. Dujardin, and A. Leentjens. “Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain Changes.” Journal of Parkinson's Disease, 2022.

G. Reynolds, M. Saint-Hilaire, Cathi A Thomas, D. Barlow, and A. Cronin-Golomb. “Cognitive-Behavioral Therapy for Anxiety in Parkinson’s Disease.” Behavior Modification, 2019.

I. Berardelli, M. Bloise, M. Bologna, A. Conte, M. Pompili, D. Lamis, M. Pasquini, and G. Fabbrini. “Cog- nitive Behavioral Group Therapy Versus Psychoeducational Intervention in Parkinson’s Disease.” Neu- ropsychiatric Disease and Treatment, 2018.

I. Berardelli, M. Pasquini, M. Bloise, L. Tarsitani, M. Biondi, A. Berardelli, and G. Fabbrini. “CBT Group Intervention for Depression, Anxiety, and Motor Symptoms in Parkinson's Disease: Preliminary Find- ings,” 2015.

I. Berardelli, M. Pasquini, V. Roselli, M. Biondi, A. Berardelli, and G. Fabbrini. “Cognitive Behavioral Therapy in Movement Disorders: A Review.” Movement Disorders Clinical Practice, 2015.

I. Koychev, and D. Okai. “Cognitive–Behavioural Therapy for Non-Motor Symptoms of Parkinson's Disease: A Clinical Review.” Evidence-Based Mental Health, 2017.

J. Silver. “Cognitive Therapy for Parkinson Disease,” 2014.

M. Kraepelien, Robert Schibbye, Kristoffer N. T. Månsson, C. Sundström, Sara Riggare, G. Andersson, N. Lindefors, P. Svenningsson, and V. Kaldo. “Individually Tailored Internet-Based Cognitive-Behavioral Therapy for Daily Functioning in Patients with Parkinson’s Disease: A Randomized Controlled Trial.” Journal of Parkinson's Disease, 2020.

M. Meyer, S. Colnat-Coulbois, S. Frismand, P. Vidailhet, P. Llorca, E. Spitz, and R. Schwan. “Parkinson's Disease and Bilateral Subthalamic Nuclei Deep Brain Stimulation: Beneficial Impact of a Preoperative Cognitive Restructuration Therapy on Postoperative Social Adjustment.” World Neurosurgery, 2020.

Maria E. A. Armento, M. Stanley, L. Marsh, M. Kunik, M. York, A. L. Bush, and Jessica S. Calleo. “Cogni- tive Behavioral Therapy for Depression and Anxiety in Parkinson's Disease: A Clinical Review.” Journal of Parkinson's Disease, 2012.

Mohammad Delshadi, Hasan Arjmand, Shima Imannezhad, Maryam Mostafavi, Yasaman Mohammadi, and Mahdi Naeim. “Quality of Life and Depression in Patients with Parkinson’s Disease: Effectiveness of Group Cognitive-Behavioral Therapy: A Randomized Controlled Study.” Annals of Medicine and Surgery, 2024.

Nicolò Zarotti, F. Eccles, J. Foley, A. Paget, Sarah Gunn, I. Leroi, and J. Simpson. “Psychological Inter- ventions for People with Parkinson's Disease in the Early 2020s: Where Do We Stand?” Psychology and Psychotherapy, 2020.

Qi Zhang, Xiaoyan Yang, Huimin Song, and Yi Jin. “Cognitive Behavioral Therapy for Depression and Anxiety of Parkinson's Disease: A Systematic Review and Meta-Analysis.” Complementary Therapies in Clinical Practice, 2020.

R. Dobkin, A. Tröster, J. T. Rubino, L. Allen, M. Gara, M. Mark, and M. Menza. “Neuropsychological Outcomes After Psychosocial Intervention for Depression in Parkinson's Disease.” The Journal of Neuropsychiatry and Clinical Neurosciences, 2014.

R. Dobkin, A. Tröster, J. T. Rubino, PsyD, A. Lesley, Allen, M. Gara, M. Mark, and M. Menza. “Neuropsychological Outcomes Following Psychosocial Intervention for Depression in Parkinson’s Disease,” 2014.

R. Dobkin, M. Menza, L. Allen, M. Gara, M. Mark, Jade Tiu, K. Bienfait, and J. Friedman. “Cognitive- Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial.” American Journal of Psychiatry, 2011.

R. Dobkin, S. Mann, A. Interian, M. Gara, and M. Menza. “Cognitive Behavioral Therapy Improves Diverse Profiles of Depressive Symptoms in Parkinson's Disease.” International Journal of Geriatric Psychiatry, 2019.

R. Dobkin, S. Mann, M. Gara, A. Interian, Kailyn M. Rodriguez, and M. Menza. “Telephone-Based Cognitive Behavioral Therapy for Depression in Parkinson Disease.” Neurology, 2020.

Rokas Perskaudas, Catherine E. Myers, A. Interian, M. Gluck, Mohammad M. Herzallah, Allan Baum, and R. Dobkin. “Reward and Punishment Learning as Predictors of Cognitive Behavioral Therapy Response in Parkinson’s Disease Comorbid with Clinical Depression.” Journal of Geriatric Psychiatry and Neurology, 2023.

Ryan J. Piers, T. Farchione, Bonnie Wong, A. J. Rosellini, and A. Cronin-Golomb. “Telehealth Transdiagnos- tic Cognitive Behavioral Therapy for Depression in Parkinson's Disease: A Pilot Randomized Controlled Trial.” Movement Disorders Clinical Practice, 2022.

S. Egan, K. Laidlaw, and S. Starkstein. “Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease.” Journal of Parkinson's Disease, 2015.

Saad Mahmoud, Nawal A. Abu Shady, and Ehab Shaker. “Parkinson ’ s Disease Current Awareness Bulletin,” 2017.

Seyedeh Arefeh Rezazadeh Yazd, Sahar Gashtil, Mahboobeh Moradpoor, Sedigheh Pishdar, Pantea Nabian, Zahra Kazemi, and M. Naeim. “Reducing Depression and Anxiety Symptoms in Patients with Parkinson's Disease: The Effectiveness of Group Cognitive Behavioral Therapy.” Parkinsonism & Related Disorders, 2023.

Shnehal Patel, Anwar Ahmed, N. Foldvary-Schaefer, O. Ojo, G. Genc, Srivadee Oravivattanakul, and H. Fernandez. “A Computerized Cognitive Behavioral Therapy Randomized, Controlled, Pilot Trial for Insomnia in Parkinson's Disease (ACCORD-PD Study) (P4.333).” Neurology, 2016.

Sneha Lopes, S. Khan, and S. Chand. “The Growing Role of Cognitive Behavior Therapy in the Treatment of Parkinson’s Disease.” Journal of Geriatric Psychiatry and Neurology, 2021.

T. D'arrigo. “Phone CBT Effective for Patients With Parkinson’s Disease,” 2020.

V. Wuthrich, and R. Rapee. “Telephone-Delivered Cognitive Behavioural Therapy for Treating Symptoms of Anxiety and Depression in Parkinson’s Disease: A Pilot Trial.” Clinical Gerontologist, 2019

Zhu Zhi-qing. “Psychological Interventions on Life Quality of Parkinson s Patients,” 2012.

Downloads

Published

2025-05-21

How to Cite

Mohammad Jathy Oktariansyah, Fifa Yuniarmi, Kanuyasa Widyatama, and Alestya Putri Jathy. 2025. “What Are The Long-Term Psychological And Quality Of Life Outcomes For Parkinson’s Disease Patients Receiving Cognitive Behavioral Therapy Interventions? : A Systematic Review”. The International Journal of Medical Science and Health Research 12 (6): 1-48. https://doi.org/10.70070/h1n1wk58.